These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 37697)

  • 41. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
    J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.
    Street JS; Clark WS; Gannon KS; Cummings JL; Bymaster FP; Tamura RN; Mitan SJ; Kadam DL; Sanger TM; Feldman PD; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2000 Oct; 57(10):968-76. PubMed ID: 11015815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.
    Nasrallah HA; Silva R; Phillips D; Cucchiaro J; Hsu J; Xu J; Loebel A
    J Psychiatr Res; 2013 May; 47(5):670-7. PubMed ID: 23421963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.
    Pivac N; Kozaric-Kovacic D; Muck-Seler D
    Psychopharmacology (Berl); 2004 Oct; 175(4):451-6. PubMed ID: 15064916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Penfluridol: a long acting oral antipsychotic drug.
    Claghorn JL; Mathew RJ; Mirabi M
    J Clin Psychiatry; 1979 Feb; 40(2):107-9. PubMed ID: 368045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trial.
    Ryan A; Baker A; Dark F; Foley S; Gordon A; Hatherill S; Stathis S; Saha S; Bruxner G; Beckman M; Richardson D; Berk M; Dean O; McGrath J; Group CW; Scott J
    Trials; 2017 Apr; 18(1):165. PubMed ID: 28388932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials.
    Citrome L; Yang R; Glue P; Karayal ON
    Schizophr Res; 2009 Jun; 111(1-3):39-45. PubMed ID: 19375893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
    J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    Weiser M; Levi L; Burshtein S; Hagin M; Matei VP; Podea D; Micluția I; Tiugan A; Păcală B; Grecu IG; Noy A; Zamora D; Davis JM
    J Clin Psychiatry; 2017 Jul; 78(7):e758-e765. PubMed ID: 28541645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quetiapine in adolescents with non-affective psychotic disorders: an open-label trial.
    Holzer L; Preuss U; Baumgartner L; Jaugey L; Urben S; Halfon O; Baumann P
    Pharmacopsychiatry; 2011 May; 44(3):87-95. PubMed ID: 21318938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post-hoc analysis.
    Deberdt WG; Siegal A; Ahl J; Meyers AL; Landbloom R
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):364-9. PubMed ID: 17708584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does a four-week delay in the introduction of medication alter the course of functional psychosis?
    Johnstone EC; Owens DG; Crow TJ; Davis JM
    J Psychopharmacol; 1999; 13(3):238-44. PubMed ID: 10512078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis.
    Oosthuizen P; Emsley R; Jadri Turner H; Keyter N
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):125-31. PubMed ID: 15003147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antipsychotic drugs: clinical pharmacology and therapeutic use.
    Davis JM; Casper R
    Drugs; 1977 Oct; 14(4):260-82. PubMed ID: 21069
    [No Abstract]   [Full Text] [Related]  

  • 58. Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects.
    Wright G; Galloway L; Kim J; Dalton M; Miller L; Stern W
    J Clin Psychiatry; 1985 Jan; 46(1):22-5. PubMed ID: 2856918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
    Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR
    JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.